Cargando…
Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study
The pharmacokinetic variability of tacrolimus can be partly explained by CYP3A5 activity. Our objective was to evaluate a tacrolimus sparing policy on renal graft outcome according to CYP3A5 6986A>G genetic polymorphism. This retrospective study included 1114 recipients with a median follow-up of...
Autores principales: | Lenain, Rémi, Maanaoui, Mehdi, Hamroun, Aghilès, Larrue, Romain, Van Der Hauwaert, Cynthia, Gibier, Jean-Baptiste, Gnemmi, Viviane, Gomis, Sébastien, Labalette, Myriam, Broly, Franck, Hennart, Benjamin, Pottier, Nicolas, Hazzan, Marc, Cauffiez, Christelle, Glowacki, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539387/ https://www.ncbi.nlm.nih.gov/pubmed/34683143 http://dx.doi.org/10.3390/jpm11101002 |
Ejemplares similares
-
Caveolin-1 rs4730751 single-nucleotide polymorphism may not influence kidney transplant allograft survival
por: Maanaoui, Mehdi, et al.
Publicado: (2019) -
Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation
por: Van der Hauwaert, Cynthia, et al.
Publicado: (2015) -
Diagnostic utility of whole-genome sequencing for nephronophthisis
por: Larrue, Romain, et al.
Publicado: (2020) -
Post-Transplantation Early Blood Transfusion and Kidney Allograft Outcomes: A Single-Center Observational Study
por: Khedjat, Kahina, et al.
Publicado: (2022) -
Correction to: COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist
por: Laboux, Timothée, et al.
Publicado: (2021)